Results 231 to 240 of about 217,671 (368)

A review of the putative antiseizure and antiepileptogenic mechanisms of action for soticlestat

open access: yesEpilepsia, EarlyView.
Abstract Soticlestat (TAK‐935) is a potent and selective inhibitor of cholesterol 24‐hydroxylase (CYP46A1), an enzyme primarily expressed in the brain that catabolizes cholesterol to 24S‐hydroxycholesterol (24HC). In the ELEKTRA phase II clinical trial, soticlestat reduced seizure frequency in patients with developmental and epileptic encephalopathies,
Shinichi Kondo   +6 more
wiley   +1 more source

Involvement of N-rnethy1-D-aspartic acid (NMDA) receptor in the central mechanism of cough reflex

open access: gold, 1990
Hideo Honda   +5 more
openalex   +1 more source

Toward molecular phenotyping of temporal lobe epilepsy by spatial omics

open access: yesEpilepsia, EarlyView.
Abstract Objective In temporal lobe epilepsy (TLE), detection of the epileptogenic zone predicts a good surgical outcome. When submitted to 18F‐fluorodeoxyglucose positron emission tomography (PET), some patients display lateralized, focal hypometabolism in the temporal lobe (PET+), whereas others appear normometabolic (PET−).
Isabeau Vermeulen   +33 more
wiley   +1 more source

Metabolomic and proteomic stratification of equine osteoarthritis

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Equine osteoarthritis (OA) is predominantly diagnosed through clinical examination and radiography, leading to detection only after significant joint pathology. The pathogenesis of OA remains unclear and while many medications modify the disease's inflammatory components, no curative or reversal treatments exist.
James R. Anderson   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy